Effectiveness and efficiency of platelet rich plasma in the treatment of diabetic ulcers

Current Pharmaceutical Biotechnology

Volumn 16, Issue 7, 2015, Pages 630-634

  Cobos, Raquel ^a   Aizpuru, Felipe ^a   Parraza, Naiara ^a   Anitua, Eduardo ^b   Orive, Gorka ^c,d  

^a Laboratory of Public Health of Alava Public Health and Addictions Directorate Basque Government   (Spain)

^b Foundation Eduardo Anitua   (Spain)

^c UNIVERSITY OF THE BASQUE COUNTRY UPV EHU   (Spain)

^d BIOMATERIALES Y NANOMEDICINA CIBER BBN   (Spain)

Author keywords

Cost benefit analysis; Platelet rich plasma; Skin ulcers; Varicose ulcers

Indexed keywords

ARTICLE; COST EFFECTIVENESS ANALYSIS; DIABETIC FOOT; HUMAN; INFLAMMATION; META ANALYSIS (TOPIC); PLASTIC SURGERY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL (TOPIC); SKIN ULCER; SYSTEMATIC REVIEW (TOPIC); THROMBOCYTE RICH PLASMA; TISSUE REPAIR; TREATMENT OUTCOME; ANIMAL; COST BENEFIT ANALYSIS; ECONOMICS; PHYSIOLOGY; PROCEDURES; WOUND HEALING;

ANIMALS; COST-BENEFIT ANALYSIS; DIABETIC FOOT; HUMANS; PLATELET-RICH PLASMA; RANDOMIZED CONTROLLED TRIALS AS TOPIC; TREATMENT OUTCOME; WOUND HEALING;

EID: 84929497708     PISSN: 13892010     EISSN: 18734316     Source Type: Journal    
DOI: 10.2174/138920101607150427111926     Document Type: Article

References (44)

1. Scottish Intercollegiate Guidelines Network (SIGN). The care of patients with chronic leg ulcer. Edinburgh: Royal College of Physicians, 1998. Available from:http://www.show.scot.nhs.uk/sign/html/html26.htm.
2. Torra, I.B.; Joan, E.; Soldevilla, A.J.J.; Rueda, L.J. et al. Primer Estudio Nacional de Prevalencia de Úlceras de Pierna en España. Estudio GNEAUPP-UIFC-Smith & Nephew 2002-2003. Epidemiología de las úlceras venosas, arteriales, mixtas y de pie diabético. Gerokomos (Madrid). 2004, 15(4).
3. Alexiadou, K.; Doupis, J. Management of diabetic foot ulcers. Diabet. Ther., 2012, 3(1), 4.
4. Cook, J.J.; Simonson, D.C. Epidemiology and health care cost of diabetic foot problems, in the diabetic foot: Medical and surgical management, contemporary diabetes. Veves, A.; Giurini, J.M.; Logerfo, F.W. editors, 2012, Hardcover
5. Dougherty, E.J. An evidence-based model comparing the costeffectiveness of platelet rich plasma gel to alternative therapies for patients with nonhealing diabetic ulcers. Adv. Skin Wound Care, 2008, 21, 568-575.
6. Carter, C.A.; Jolly, D.G.; Worden, Sr C.E.; Hendren, D.G.; Kane, C.J.M. Platelet-rich plasma gel promotes differentiation and regeneration during equine wound healing. Exp. Mol. Pathol., 2003, 74, 244-255.
7. Yager, D.R.; Zhang, L.Y.; Liang, H.X.; Diegelman, R.F.; Cohen, I.K. Wound fluids from human pressure ulcers contain elevated matrix metalloproteinase levels and activity compared to surgical wound fluids. J. Invest. Dermatol., 1996, 107, 743-748.
8. Mwaura, B.; Mehendran, B.; Hynes, N.; Defreitas, D.; Avalos, G.; Adegbola, T.; Adham, M.; Connolly, C.E.; Sultan, S. The impact of differential expression of extracellular matrix metalloproteinase inducer, matrix metalloproteinase-2, tissue inhibitor of matrix metalloproteinase-2 and PDGF-AA on the chronicity of venous leg ulcers. Eur. J. Endovasc. Surg., 2006, 31, 306-310.
9. Akingboye, A.A.; Giddins, S.; Gamston, P.; Tucker, A.; Navsaria, H.; Kyriakides, C. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: Diabetic foot ulcer. J. Extra Corpor. Technol. 2010, 42(1), 20-29.
10. Anitua, E.; Sánchez, M.; Orive, G.; Andia, I. Delivering growth factors for therapeutics. Trends Pharmacol. Sci., 2008, 29(1), 37-41.
11. Anitua, E.; Andia, I.; Ardanza, B.; Nurden, P.; Nurden, A.T. Autologous platelets as a source of proteins for healing and tissue regeneration. Thromb. Haemost., 2004, 91(1), 4-15.
12. Bennett, N.T.; Schultz, G.S. Growth factors and wound healing: Biochemical properties of growth factors and their receptors. Am. J. Surg., 1993, 166, 74-81.
13. Bennett, N.T.; Schultz, G.S. Growth factors and wound healing: Part II. Role in normal and chronic wound healing. Am. J. Surg., 1993, 165, 728-737.
14. Fu, X.; Li, X.; Cheng, B.; Chen, W.; Sheng, Z. Engineered growth factors and cutaneous wound healing: Success and possible questions in the past 10 years. Wound Rep. Regen. 2005, 13, 122-130.
15. Goldman, R. Growth factors and chronic wound healing: Past, present, and future. Adv. Skin Wound Care, 2004, 17, 24-35.
16. Knighton, D.R.; Doucette, M.; Fiegel, V.D.; Ciresi, K.; Butler, E.; Austin, L. The use of platelet derived wound healing formula in human clinical trials. Prog. Clin. Biol. Res., 1988, 266, 319-329.
17. Krupski, W.C.; Reilly, L.M.; Perez, S.; Moss, K.M.; Crombleholme, P.A.; Rapp, J.H. A prospective randomized trial of autologous platelet-derived wound healing factors for treatment of chronic nonhealing wounds: A preliminary report. J. Vasc. Surg., 1991, 14, 526-532.
18. Semple, J.W.; Italiano Jr, J.E.; Freedman, J. Platelets and the immune continuum. Nat. Rev. Immunol., 2011, 11, 264-274.
19. Italiano, J.E. Jr, Richardson, J.L.; Patel-Hett, S.; Battinelli, E.; Zaslavsky, A.; Short, S.; Ryeom, S.; Folkman, J.; Klement, G.L. Angiogenesis is regulated by a novel mechanism: Pro-and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. Blood, 2008, 111, 1227-1233.
20. Lesurtel, M.; Graf, R.; Aleil, B.; Walther, D.J.; Tian, Y.; Jochum, W.; Gachet, C.; Bader, M.; Clavien, P.A. Platelet-derived serotonin mediates liver regeneration. Science, 2006, 312, 104-107.
21. Tang, Y.Q.; Yeaman, M.R.; Selsted, M.E. Antimicrobial peptides from human platelets. Infect Immun., 2002, 70, 6524-6533.
22. El-Sharkawy, H.; Kantarci, A.; Deady, J.; Hasturk, H.; Liu, H.; Alshahat, M., Van Dyke, T.E. Platelet-rich plasma: Growth factors and pro-and anti-inflammatory properties. J. Periodontol., 2007, 78, 661-669.
23. Bendinelli, P.; Matteucci, E.; Dogliotti, G.; Corsi, M.M.; Banfi, G.; Maroni, P.; Desiderio, M.A. Molecular basis of anti-inflammatory action of platelet-rich plasma on human chondrocytes: Mechanisms of NF-κB inhibition via HGF. J. Cell Physiol., 2010, 225, 757-766.
24. Ghosh, S.; Hayden, M.S. New regulators of NF-κB in inflammation. Nat. Rev. Immunol., 2010, 8, 837-847.
25. Scimeca, C.L.; Bharara, M.; Fisher, T.K.; Kimbriel, H.; Armstrong, D.G. Novel use of platelet-rich plasma to augment curative diabetic foot surgery. J. Diabet. Sci. Tecnol., 2010, 4(5), 1121-1126.
26. Lacci, K.M.; Dardik, A. Platelet-rich plasma: Support for its use in wound healing. Yale J. Biol. Med., 2010, 83(1), 1-9.
27. Whitman, D.H.; Berry, R.L.; Green, D.M. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J. Oral Maxillofac. Surg., 1997, 55(11),1294-1299.
28. Marx, R.E.; Carlson, E.R.; Eichstaedt, R.M.; Schimmele, S.R.; Strauss, J.E.; Georgeff, K.R. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg. Oral Med. Oral Pathol. Oral Radiol. Endod., 1998, 85(6), 638-46.
29. Anitua, E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int. J. Oral Maxillofac. Implants, 1999, 14(4), 529-535.
30. Mazzucco, L.; Balbo, V.; Cattana, E.; Borzini, P. Platelet-rich plasma and platelet gel preparation using Plateltex. Vox Sang., 2008, 94(3), 202-208
31. Cervelli, V.; Gentile, P.; Grimaldi, M. Regenerative surgery: Use of fat grafting combined with platelet-rich plasma for chronic lower-extremity ulcers. Aesthetic Plast. Surg., 2009, 33(3), 340e5.
32. Hospedales, J.; Ferré, J.; Mestres, J.M. Úlceras de las EEII: Diagnóstico diferencial y guía de tratamiento. Anales de Cirugía Cardíaca y Vascul., 2001, 7, 253-270.
33. Tennvall, G.R.; Hjelmgren, J.; őlien, R. The cost of treating hard to heal venous leg ulcers: Results from a Swedish survey. World Wide Wounds 2006. URL http://www.worldwidewounds.com/ 2006/november/Tennvall/Cost-of-treating-hard-to-heal-venous-legulcers. html accessed on 19 September 2011..
34. London, N.J.M.; Donnelly, R. Ulcerated lower limb. Brit. Medical J., 2000, 320, 1589-1591.
35. Marx, R.E. Platelet rich plasma: Evidence to support its use. J. Oral Maxillofac. Surg., 2004, 62(4), 479-496.
36. Villela, D.L.; Santos, V.L. Evidence on the use of platelet-rich plasma for diabetic ulcer: A systematic review. Growth Factors, 2010, 28(2), 111-116.
37. Martinez-Zapata, M.J.; Martí-Carvajal, A.J.; Solà, I.; Expósito, J.A.; Bolíbar, I.; Rodríguez, L.; Garcia, J. Autologous platelet-rich plasma for treating chronic wounds. Cochrane Database Syst. Rev., 2012, 10, CD006899. doi: 10.1002/14651858.CD006899.pub2.
38. Lacci, K.M.; Dardik, A. Platelet-rich plasma: support for its use in wound healing. Yale J. Biol. Med., 2010, 83(1), 1-9.
39. Astrid, L.; Rogowski, W. Systematic review of economic evaluations of human cell-derived wound care products for the treatment of venous leg and diabetic foot ulcers. BMC Health Services Res., 2009, 9, 115
40. Dougherty, E.J. An evidence-based model comparing the costeffectiveness of platelet-rich plasma gel to alternative therapies for patients with non-healing diabetic foot ulcers. Adv. Skin Wound Care, 2008, 21(12), 568-575.
41. Cobos, R.; Parraza, D.; Aizpuru, F. Platelet rich plasma in skin ulcers treatment. Wounds, 2013, 25(9), 256-262.
42. Senet, P.; Bon, F.X.; Benbunan, M.; Bussel, A.; Traineau, R.; Calvo, F.; Dubertret, L.; Dosquet, C. Randomized trial and local biological effect of autologous platelets used as adjuvant therapy for chronic venous leg ulcers. J. Vascul. Surg., 38(6), 1342-1348.
43. Akingbove, A.A.; Giddins, S.; Gamston, P.; Tucker, A.; Navsaria, H.; Kyriakides, C. Application of autologous derived-platelet rich plasma gel in the treatment of chronic wound ulcer: Diabetic foot ulcer. J. Extra Corpor. Technol., 2010, 42(1), 20-29.
44. Valbonesi, M.; Giannini, G.; Migliori, F.; Dalla, C.R.; Galli, A. The role of autologous fibrin-platelet glue in plastic surgery: A preliminary report. Int. J. Artif. Organs, 2002, 25, 334-338.